Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
JW (Cayman) Therapeutics Co. Ltd. ( (HK:2126) ) has provided an announcement.
JW (Cayman) Therapeutics Co. Ltd. announced the closure of its register of members from May 29 to June 3, 2025, to determine shareholders eligible to attend and vote at the upcoming Extraordinary General Meeting (EGM) on June 3, 2025. This announcement is significant as it outlines the procedural steps for shareholder participation, potentially impacting shareholder engagement and decision-making processes within the company.
More about JW (Cayman) Therapeutics Co. Ltd.
JW (Cayman) Therapeutics Co. Ltd. is a company incorporated in the Cayman Islands, focusing on therapeutic solutions. It operates within the biotechnology industry, with a market focus on developing innovative treatments.
Average Trading Volume: 2,045,736
Technical Sentiment Signal: Sell
Current Market Cap: HK$670.1M
For an in-depth examination of 2126 stock, go to TipRanks’ Stock Analysis page.